Advanced search
Instruments
| Name | Stock exchange | Average volume | Price | Type | ||
|---|---|---|---|---|---|---|
| NASH DOM BULGARIA HOLDING AD | HDOM | Bulgaria S.E. +1 Other | 8 |
0.061
BGN
 | Stock | |
| NASH DOM BULGARIA HOLDING AD | 0OI9 | London S.E. | - | - BGN
| ||
 THE MEET KEVIN PRICING POWER ETF - USD | PP | Nyse | 20,414 |
27.02
USD
| ETF |
News (535)
Companies (49)
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directe ...
Ingersoll Rand Inc. specializes in the design, manufacture and marketing of industrial technological equipment. The group provides compressed air equipment (screw compressors, reciprocating compressors, centrifugal compressors, air dryers, air filters, et ...
Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations. Its product ...
International Star, Inc. operates, through its wholly owned subsidiary, Budding Equity Inc., a royalty-based business that owns intellectual property contracts with movie studios, which provide for the licensing of that intellectual property (IP) to third ...
Akero Therapeutics, Inc. is a clinical-stage company. The Company is developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including metabolic dysfunction-associated steatohepatitis (MASH), ...
CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (C ...
Nash Dom Bulgaria Holding AD Sofia (Nash Dom-Bulgaria AD-Holding or Nash Dom Bulgaria Holding PLC) is a Bulgaria-based holding company that is principally engaged in the acquisition, appraisal and managing of shares in companies active in the food process ...
Ascletis Pharma Inc is a China-based investment holding company principally engaged in the research, development, production, marketing and sales of pharmaceutical products. The Company mainly focuses on viral diseases, non-alcoholic steatohepatitis (NASH ...
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for treatment of metabolic and endocrine disorders. The Company's clinical programs include VK2809, an orally available, small molecule ...
Poxel is a biopharmaceutical company specializing in developing innovative treatments for metabolic diseases, including non-alcoholic steatohepatitis (NASH) and rare diseases. TWYMEEG® (Imeglimine), Poxel's lead product and the first in its class of medi ...
Insiders
Kevin Nash worked as Vice President-Communications at Advance Auto Parts, Inc. from 2018 to 2019.
Mr. Kevin C. Nash is a Treasurer, Chief Financial & Accounting Officer at Gentex Corp. He is on the Board of Directors at Air-Craftglass Production BVBA. Mr. Nash was previously employed as a Senior Accountant by ODL, Inc. He received his undergraduate degree from Hope College.
Keith Nash is currently working as the Director of Human Resources at Badenoch & Clark Ltd.
since 2004 and as the Executive Director & Director of Human Resources at NHS Professionals Ltd.
since 2009.
Previously, he worked as the Director of Human Resources at Cable & Wireless Ltd., Inchcape Plc, and Coca-Cola Europacific Partners Great Britain Ltd.
Steven Garry Nash currently works at BEN-Motor & Allied Trades Benevolent Fund, as Chairman from 2018 and Morgal Machine Tool Co., Inc., as Chief Engineering Officer.
No results for this search
- Stock Market
- Advanced search
- Kevin Nash
